It is reasonable to hypothesize that, compared to MCD, urinary EGF expression decreases more in FSGS, IgAN, and other glomerulopathies due to more pronounced glomerular damage and podocyte dropout. This evidence concerns the gene EGF and focal segmental glomerulosclerosis.